LAS VEGAS — Enhanced Group, Inc. hosted the inaugural Enhanced Games in Las Vegas, Nevada, over Memorial Day weekend in 2026. The event featured 42 athletes—including weightlifters, swimmers, and track runners—who openly used performance-enhancing drugs such as anabolics, testosterone, peptides, and human growth hormones under medical supervision.

Athletes participated in a 12-week training program in the United Arab Emirates prior to the competition, during which they received individually tailored drug regimens referred to as 'protocols.' Enhanced Group, Inc. markets the event as a model of safer, medically supervised performance enhancement, arguing that many athletes already use such substances secretly without oversight.

Competitors received appearance fees and stood to earn up to $1 million in prize money for breaking world records in events like the 100-meter sprint and 50-meter freestyle. Canadian weightlifter Boady Santavy attempted to break the men’s snatch world record of 183 kilograms but failed to complete a successful lift and left the platform visibly upset.

Approximately 200 journalists from around the world attended the event. Enhanced Group, Inc. is a newly public company that held its initial public offering in May 2026 with a $1.2 billion valuation. The company sells personalized health treatments, including peptides, GLP-1s for weight loss, and testosterone injections, all of which have been cleared by the FDA.

Enhanced Group, Inc. was founded by veterans of crypto, AI, and biotech firms and has received backing from investor Peter Thiel and former Coinbase executive Balaji Srinivasan. The company also partnered with AI firm Rezolve Ai to launch a digital telehealth platform.

Critics have condemned the event. The World Anti-Doping Agency called the Enhanced Games 'dangerous.' Travis Tygart, CEO of the U.S. Anti-Doping Agency, described the competition as a 'clown show that puts profit over people.'

The FDA will convene a pharmaceutical advisory committee in July 2026 to consider whether restrictions on certain previously banned peptides should be loosened.